The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease

被引:3
|
作者
Trojan, Vaclav [1 ]
Landa, Leos [1 ,2 ]
Sulcova, Alexandra [1 ]
Sliva, Jiri [3 ]
Hrib, Radovan [1 ,4 ]
机构
[1] St Annes Univ Hosp, Int Clin Res Ctr, Cannabis Facil, Pekarska 53, Brno 60200, Czech Republic
[2] Masaryk Univ, Fac Med, Dept Pharmacol, Kamenice 5, Brno 62500, Czech Republic
[3] Charles Univ Prague, Fac Med 3, Dept Pharmacol, Ruska 87, Prague 10000, Czech Republic
[4] St Annes Univ Hosp, Ctr Pain Management, Dept Anesthesiol & Intens Care, Pekarska 53, Brno 60200, Czech Republic
关键词
cannabidiol; aging; Alzheimer's disease; cannabinoids; ENDOCANNABINOID SYSTEM; MEDICAL CANNABIS; DRUG; INHIBITOR; UPDATE; TARGET; SAFETY; UCM707; TRIAL;
D O I
10.3390/biom13101446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of cannabinoids (substances contained specifically in hemp plants) for therapeutic purposes has received increased attention in recent years. Presently, attention is paid to two main cannabinoids: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). With respect to the psychotropic effects and dependence potential of THC (though it is very mild), its use is associated with certain restrictions, and thus the therapeutic properties of CBD are frequently emphasized because there are no limitations associated with the risk of dependence. Therefore, this review covers the main pharmacodynamic and pharmacokinetic features of CBD (including characteristics of endocannabinoidome) with respect to its possible beneficial effects on selected diseases in clinical practice. A substantial part of the text deals with the main effects of CBD on aging, including Alzheimer's disease and related underlying mechanisms.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Beneficial Effects of Fingolimod in Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Potential
    Efthalia Angelopoulou
    Christina Piperi
    NeuroMolecular Medicine, 2019, 21 : 227 - 238
  • [32] Therapeutic Potential of Baicalein in Alzheimer’s Disease and Parkinson’s Disease
    Yanwei Li
    Jinying Zhao
    Christian Hölscher
    CNS Drugs, 2017, 31 : 639 - 652
  • [33] Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease
    Li, Yanwei
    Zhao, Jinying
    Holscher, Christian
    CNS DRUGS, 2017, 31 (08) : 639 - 652
  • [34] Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer's disease
    Leszko, Magdalena
    Meenrajan, Senthil
    COMPLEMENTARY THERAPIES IN MEDICINE, 2021, 57
  • [35] Neurobiological Effects of Hyperforin and its Potential in Alzheimer's Disease Therapy
    Griffith, T. N.
    Varela-Nallar, L.
    Dinamarca, M. C.
    Inestrosa, N. C.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (05) : 391 - 406
  • [36] Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications
    Noreen, Nida
    Muhammad, Faqir
    Akhtar, Bushra
    Azam, Farooq
    Anwar, Muhammad Irfan
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2018, 28 (01): : 73 - 86
  • [37] Clusterin is a Potential Therapeutic Target in Alzheimer's Disease
    Palihati, Nazhakaiti
    Tang, Yuanhong
    Yin, Yajuan
    Yu, Ding
    Liu, Gang
    Quan, Zhenzhen
    Ni, Junjun
    Yan, Yan
    Qing, Hong
    MOLECULAR NEUROBIOLOGY, 2023, 61 (7) : 3836 - 3850
  • [38] Ferroptosis, a Potential Therapeutic Target in Alzheimer's Disease
    Chen, Kai
    Jiang, Xiaobing
    Wu, Moxin
    Cao, Xianming
    Bao, Wendai
    Zhu, Ling-Qiang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [39] Therapeutic Potential of Ferulic Acid in Alzheimer's Disease
    Turkez, Hasan
    Arslan, Mehmet Enes
    Barboza, Joice Nascimento
    Kahraman, Cigdem Yuce
    de Sousa, Damiao Pergentino
    Mardinoglu, Adil
    CURRENT DRUG DELIVERY, 2022, 19 (08) : 860 - 873
  • [40] Probiotics as potential therapeutic options for Alzheimer's disease
    Ji, Hong-Fang
    Shen, Liang
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 105 (20) : 7721 - 7730